top of page
  • Linkedin

The Team

Martin_edited.png

Founder & CSO

Professor Martin Griffin

Professor in Biochemistry. Over four decades in Transglutaminase research; over 200 publications; and senior leadership roles in HE sector.

Vivian_edited_edited.png

Founder and COO

Dr Zhuo (Vivian) Wang

Senior Lecturer in Biology; 19 years in Transglutaminase research; 8 years in medical training.

Angela_edited.png

CEO

Dr Angela Jeffery

Over 20 years in technology transfer in biotech and life sciences, fund raising, licencing and strategic partnerships.

Liz_edited_edited_edited_edited_edited.p

CFO

Liz Dainty

9 years of spinout CFO experience.

Kaouthar_edited_edited_edited_edited_edi

Research Scientist

Dr Kaouthar Bouzinab

Specialised in advanced therapeutics, nanomedicine and pre-clinical research.

Laura.png

Researh Scientist

Dr Laura Hawkins

Speclialised in translational research with expertise in molecular biology and preclinical model development.

Building on nearly 6 decades of world leading experience in TG2

kleis square logo.png

© 2026 Kleis Therapeutics Ltd. All rights reserved

bottom of page